A new retrospective, laboratory-based observational study provides detailed insights into the causes of fevers of unknown origin in sub-Saharan Africa. Scientists examined 550 patients from Guinea who ...
A new retrospective, laboratory-based observational study provides detailed insights into the causes of fevers of unknown ...
Amid a new Ebola outbreak in Kampala, Uganda, the World Health Organization has kicked off a vaccine trial. This is the first ...
A laboratory holding Ebola and other dangerous pathogens in the eastern DR Congo city of Goma—which has been seized by the ...
No licensed vaccines or therapeutics are available for Ebola Sudan, a Category A priority pathogen. Existing Ebola Zaire vaccines are not cross-protective for Ebola Sudan. Mark Feinberg ...
Uganda started a vaccination trial on Monday for the Ebola Sudan virus four days after an outbreak was confirmed, the WHO announced, beginning with those deemed at highest risk. World Health ...
Active host-pathogen interactions take place during infection of human immunodeficiency virus type 1 (HIV-1). Outcomes of these interactions determine the efficiency of viral infection and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback